2024-11-01 2026-02-28 false No description of principal activity Capium Accounts Production 1.1 13681644 2024-11-01 2026-02-28 13681644 bus:FullAccounts 2024-11-01 2026-02-28 13681644 bus:Micro-entities 2024-11-01 2026-02-28 13681644 bus:AuditExemptWithAccountantsReport 2024-11-01 2026-02-28 13681644 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2026-02-28 13681644 bus:PrivateLimitedCompanyLtd 2024-11-01 2026-02-28 13681644 2024-11-01 2026-02-28 13681644 2026-02-28 13681644 bus:RegisteredOffice 2024-11-01 2026-02-28 13681644 core:WithinOneYear 2026-02-28 13681644 core:AfterOneYear 2026-02-28 13681644 1 2024-11-01 2026-02-28 13681644 bus:Director1 2024-11-01 2026-02-28 13681644 bus:Director1 2026-02-28 13681644 bus:Director1 2023-11-01 2024-10-31 13681644 bus:Director2 2024-11-01 2026-02-28 13681644 bus:Director2 2026-02-28 13681644 bus:Director2 2023-11-01 2024-10-31 13681644 bus:Director3 2024-11-01 2026-02-28 13681644 bus:Director3 2026-02-28 13681644 bus:Director3 2023-11-01 2024-10-31 13681644 bus:Director4 2024-11-01 2026-02-28 13681644 bus:Director4 2026-02-28 13681644 bus:Director4 2023-11-01 2024-10-31 13681644 bus:Director5 2024-11-01 2026-02-28 13681644 bus:Director5 2026-02-28 13681644 bus:Director5 2023-11-01 2024-10-31 13681644 2023-11-01 13681644 bus:LeadAgentIfApplicable 2024-11-01 2026-02-28 13681644 2023-11-01 2024-10-31 13681644 2024-10-31 13681644 core:WithinOneYear 2024-10-31 13681644 core:AfterOneYear 2024-10-31 13681644 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 13681644 core:CostValuation core:Non-currentFinancialInstruments 2026-02-28 13681644 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 13681644 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13681644 core:Non-currentFinancialInstruments 2026-02-28 13681644 core:Non-currentFinancialInstruments 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13681644
England and Wales

 

 

 

UPACARE HEALTH LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 November 2024

End date: 28 February 2026
  2026   2024
    £ £   £ £
Current assets 1,092      403,479   
Creditors: amount falling due within one year (46,910)     (342,092)  
Net current assets   (45,818)     61,387 
Total assets less current liabilities   (45,818)     61,387 
Net assets   (45,818)     61,387 
 

         
Capital and reserves   (45,818)     61,387 
 
NOTES TO THE ACCOUNTS

General Information
UpaCare Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 13681644, registration address 17 Main Street, Ponteland, Tyne & Wear, NE20 9NH.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis

The Company ceased trading on 28th February 2026.
2.

Average number of employees

Average number of employees during the period was 5 (2024 : 5).


For the period ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 01 May 2026 and were signed on its behalf by:


--------------------------------
Sumitra Kafle-Nath
Director
1